Long or Very Long-Limb Gastric Bypass in Superobese
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00868543 |
|
Recruitment Status : Unknown
Verified March 2009 by Kaunas University of Medicine.
Recruitment status was: Recruiting
First Posted : March 25, 2009
Last Update Posted : March 25, 2009
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Obesity | Procedure: laparoscopic gastric Roux-en-Y gastric bypass | Phase 3 |
The study is a multicentre trial in which superobese (BMI>50) patients will be randomly assigned (in a 1:1 ratio) for laparoscopic gastric Roux-en-Y gastric bypass with: a) long (150 cm) or b) very long (250cm) alimentary Roux limb. Patients will be included from three hospitals: Kaunas University of Medicine Hospital (Lithuania), Klaipeda District Hospital (Lithuania), Vaasa Central Hospital (Finland) ) where preoperative investigation, the same technique surgical procedures and follow up will be performed acording approved protocol.
Approximate duration of subject participation
Subjects in the study will participate for approximately 5 years:
- Preoperative investigation and surgery 3- 5 days in the hospital;
- First follow up visit: 6 months after surgery;
- Next follow up visits: 12, 24, 36, 48 months after surgery;
- Last follow up visit: 5 years after surgery.
- The interim results after 12, 24 and 36 months will be calculated and presented before end of the study.
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 150 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Participant) |
| Primary Purpose: | Treatment |
| Official Title: | Long or Very Long-Limb Gastric Bypass in Superobese |
| Study Start Date : | July 2008 |
| Estimated Primary Completion Date : | July 2013 |
| Estimated Study Completion Date : | December 2015 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: Long limb
Hospitalized male or female subjects 18-65 years of age,obese with body mass index (BMI= kg/m²)>50.Patients without mental or nervous disorders interfering with adequate evaluation of one's health condition, who read the informed consent form and gave a written consent to participate in the study. Gastric bypass was performed with long (150 cm) alimentary Roux limb
|
Procedure: laparoscopic gastric Roux-en-Y gastric bypass
The fundus is separated by linear cutter. The intestine is opened approximately 75 cm from the ligament of Treitz and approached to the stomach. The gastrojejunostomy is performed in antecolic position The jejunum has to be in an antimesenteric position. After removing the endocutter, the anastomotic incision is closed with a continuous suture. The distance between the gastrojejunostomy and jejunojejunostomy was measured on the antimesenteric border with the bowel on a stretch. The jejunojejunostomy is performed in 150cm distance from gastrojejunostomy. The anastomosis is made by a posterior staple line and an anterior suture line. Preparation of a small window for the endocutter branches into the jejunal mesenterium 2-3 cm proximal to the gastrojejunostomy and above the entero-intestinal anastomosis.
Other Name: laparoscopic gastric bypass |
|
Active Comparator: Very long limb
Hospitalized male or female subjects 18-65 years of age,obese with body mass index (BMI= kg/m²)>50.Patients without mental or nervous disorders interfering with adequate evaluation of one's health condition, who read the informed consent form and gave a written consent to participate in the study. Gastric bypass was performed with very long (250 cm) alimentary Roux limb
|
Procedure: laparoscopic gastric Roux-en-Y gastric bypass
The fundus is separated by linear cutter. The intestine is opened approximately 75 cm from the ligament of Treitz and approached to the stomach. The gastrojejunostomy is performed in antecolic position The jejunum has to be in an antimesenteric position. After removing the endocutter, the anastomotic incision is closed with a continuous suture. The distance between the gastrojejunostomy and jejunojejunostomy was measured on the antimesenteric border with the bowel on a stretch. The jejunojejunostomy is performed in 250cm distance from gastrojejunostomy. The anastomosis is made by a posterior staple line and an anterior suture line. Preparation of a small window for the endocutter branches into the jejunal mesenterium 2-3 cm proximal to the gastrojejunostomy and above the entero-intestinal anastomosis.
Other Name: laparoscopic gastric bypass |
- weight loss- we will compare percentage of excess body weight loss (%EWL) between groups. [ Time Frame: 7 years ]
- To compare body mass index changes and absolute weight loss. To evaluate obesity-related medical problems. To obtain data about impromvement of metabolic syndrom. To compare quality of life changes between treatment arms. [ Time Frame: 7 years ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 65 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Hospitalized male or female subjects 18-65 years of age.
- Obese subjects with body mass index (BMI= kg/m²)>50
- Patients without mental or nervous disorders interfering with adequate evaluation of one's health condition.
- Patients who read the informed consent form and gave a written consent to participate in the study.
Exclusion Criteria:
- Previous open abdominal surgery, except appendectomy, cholecystectomy and gynaecological procedures.
- Presence of any significance cardiac, hepatic, renal, blood, alimentary tract disease which may lead to system or organ failure in intraoperative or postoperative period.
- Pregnant women.
- Subjects taking immunosuppressive therapy.
- Any concomitant condition that, in the opinion of the investigator, would preclude an operation and postoperative follow up acording to a protocol
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00868543
| Contact: Nerijus Kaselis | +37069943431 | nkaselis@gmail.com | |
| Contact: Almantas Maleckas | +37068531143 |
| Lithuania | |
| KMUK, surgery department | Recruiting |
| Kaunas, Lithuania, 50009 | |
| Contact: Nerijus Kaselis +37069943431 nkaselis@gmail.com | |
| Principal Investigator: Nerijus Kaselis | |
| Principal Investigator: | Almantas Maleckas | Kaunas University of Medicine |
| Responsible Party: | Almantas Maleckas, Kaunas University of Medicine |
| ClinicalTrials.gov Identifier: | NCT00868543 |
| Other Study ID Numbers: |
BE-2-37 |
| First Posted: | March 25, 2009 Key Record Dates |
| Last Update Posted: | March 25, 2009 |
| Last Verified: | March 2009 |
|
Gastric bypass obesity superobese |
|
Obesity Overnutrition Nutrition Disorders Overweight Body Weight |

